ÂÜÀòÂÒÂ×

Valeriia Kuzyk is a Field Application Scientist at Bruker since February 2022, with an extensive academic and research background. Currently pursuing a PhD at Vrije Universiteit Amsterdam under the GlyCoCan Marie Curie ITN grant, Valeriia's previous roles include Senior Associate Scientist at Johnson & Johnson, focusing on RSV adenoviral vaccine formulation, and Scientist Academy at Procam. Valeriia has experience as a Visiting PhD Student at Ludger Limited, specializing in characterizing glycosylated proteins, and worked as an Assistant at the Institute of Cytology RAS, where analysis of proteasome-associated proteomes was conducted. Valeriia holds multiple master's degrees in Bioinformatics and Biochemistry, as well as a bachelor's degree in Cytology and Histology from Saint Petersburg State University, and has a background in computer-aided drug design from the University of Turku.